We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

The Effect of Intermittent Rifampicin on Raltegravir (RIFRAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01424826
Recruitment Status : Completed
First Posted : August 29, 2011
Last Update Posted : October 31, 2013
Royal Liverpool and Broadgreen University Hospitals NHS Trust
Information provided by (Responsible Party):
Helen Reynolds, University of Liverpool

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2013
  Study Completion Date : July 2013